Tyr329
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Tyr329 - CYP17A1 (human)

Site Information
PQVKKKLyEEIDQNV   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: CYP17A1 (rat): (Q328), CYP17A1 (mouse): (Q328)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 464736

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2)
Disease tissue studied: leukemia (1, 2), chronic myelogenous leukemia (1, 2)
Relevant cell line - cell type - tissue: K562 (erythroid) (1, 2)




References

1

Moritz A (2006) CST Curation Set: 1538; Year: 2006; Biosample/Treatment: cell line, K562/-; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

2

Moritz A (2006) CST Curation Set: 1461; Year: 2006; Biosample/Treatment: cell line, K562/-; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.